Platelet Rich Plasma Therapy

There is something quietly extraordinary about the idea that your own blood holds the blueprint for your healing. Before a single injection is prepared, before a centrifuge spins, the raw materials for regeneration are already circulating inside you — waiting to be called upon.

Platelet rich plasma therapy draws on that understanding. It takes a concentrated portion of your own blood, rich with the growth factors that govern tissue repair, and delivers it precisely where your body has stalled — whether that's a thinning hairline, aging skin, a slow-healing wound, or a joint worn down by years of use. The result is a treatment that works with your biology rather than overriding it.

At RegenLife, clinicians see PRP not as a standalone fix but as a catalyst. It initiates and amplifies the body's natural healing cascade in ways that support longer-lasting recovery and renewal. This guide covers what platelet rich plasma therapy is, how it works across different areas of care, and how to know whether it aligns with your healing goals.

Key Takeaways

• Platelet rich plasma therapy concentrates your own blood's healing factors — at levels five to ten times above baseline — and delivers them directly to tissue that needs repair
• The strongest evidence supports PRP for androgenetic hair loss, skin rejuvenation, chronic wound healing, and certain musculoskeletal conditions
• A 2025 systematic review of 43 randomized controlled trials found activated PRP significantly increases hair density and reduces ongoing hair loss compared to placebo
• Most patients require a short series of sessions followed by periodic maintenance, with results emerging gradually over weeks to months
• Because PRP uses autologous material — your own blood — the safety profile is consistently favorable across the literature

What Platelet Rich Plasma Therapy Actually Is

The Blood Behind the Treatment

Blood is not a uniform fluid. It carries distinct components — red blood cells transporting oxygen, white blood cells managing immunity, and platelets overseeing the body's immediate response to injury. Suspended in plasma, platelets are small, fragment-like cells that do far more than form clots. They store and release concentrated signals that tell surrounding tissue to begin rebuilding.

In a normal blood sample, platelet concentration runs between 150,000 and 350,000 per microliter. Platelet rich plasma concentrates those platelets to three to nine times that baseline level, depending on the preparation system used. That amplification is what makes the therapy therapeutically meaningful — enough growth factor signal to wake up dormant healing pathways.

The preparation process begins with a standard blood draw of roughly 20 to 60 millilitres from a vein in the arm. The sample goes directly into a centrifuge, which spins at carefully calibrated speeds to separate the blood by density. Red blood cells settle to the bottom. White blood cells form a thin layer above them. And the platelet-rich plasma layer rises toward the top — a golden, biologically active concentrate ready for clinical use.

Growth Factors: The Signals That Drive Repair

When PRP reaches an injured or aging tissue, the platelets activate and release the contents of their internal granules. What follows is a coordinated cascade of biological signals that influence nearly every phase of healing:

• Platelet-Derived Growth Factor (PDGF) — stimulates fibroblasts to produce collagen and elastin; recruits additional repair cells to the area
• Vascular Endothelial Growth Factor (VEGF) — drives new blood vessel formation, restoring circulation and nutrient delivery to damaged tissue
• Transforming Growth Factor-Beta (TGF-β) — regulates collagen synthesis and guides tissue remodeling from fragile scar toward durable, organized structure
• Epidermal Growth Factor (EGF) — accelerates regeneration of skin and surface tissue by stimulating keratinocyte activity
• Insulin-Like Growth Factor (IGF-1) — supports cell survival, promotes follicle cycling in the scalp, and aids muscle tissue repair
• Fibroblast Growth Factor (FGF) — promotes wound contraction and dermal regeneration

Research confirms that the therapeutic power of PRP depends on the synergistic interaction of these factors working together. Isolating any single growth factor produces weaker results than the full concentrate — a reminder that biological complexity often exceeds what we can engineer in isolation.

Leukocyte-Rich vs. Leukocyte-Poor PRP

One variable that significantly shapes outcomes is whether white blood cells — leukocytes — are retained in the final PRP preparation. Leukocyte-rich PRP may enhance the antimicrobial and early inflammatory response, which can be useful for wound care. Leukocyte-poor PRP tends to produce less post-injection discomfort and is often preferred for joint and skin applications where excess inflammation could work against the treatment.

This distinction matters because not all PRP is prepared the same way. Outcomes depend on protocol, technique, platelet concentration, and the specific tissue being treated — which is why working with an experienced clinician who tailors the approach to your condition makes a meaningful difference.

PRP for Hair Restoration

Understanding Hair Loss and Its Biology

Hair loss touches something deeply personal — the way we recognize ourselves in the mirror, how we feel walking into a room. Androgenetic alopecia, the most common form, affects roughly 50% of men by age 50 and millions of women as well, progressing gradually as follicles miniaturize and the growth phase of the hair cycle shortens.

PRP addresses this at the follicular level. The scalp's dermal papilla cells — the architects of the hair cycle — respond to the growth factors in PRP by reactivating dormant follicles, extending the anagen (growth) phase, and increasing the blood supply around the follicle base. The result is thicker shafts, improved density, and a slowed rate of ongoing loss.

At RegenLife, clinicians notice that patients who begin PRP treatment while follicles are still present but miniaturized tend to see the most meaningful response. Early intervention, before follicular atrophy becomes permanent, makes the difference between restoration and maintenance.

What the Research Shows

The evidence for PRP in hair loss has matured considerably. A 2025 systematic review of 43 randomized controlled trials covering 1,877 participants found that activated PRP significantly increased hair density and minimized ongoing loss compared to placebo. Activated PRP — where the platelets are triggered before injection — consistently outperformed non-activated preparations.

Specific measurements from clinical trials give a concrete picture of what patients experience. One study documented a mean increase of 45.9 hairs per square centimetre after three treatment cycles, alongside improvements in hair shaft thickness. A comparative study between PRP and topical minoxidil found that PRP achieved a negative hair pull test rate of 91.7%, compared to 69.4% for minoxidil — a measure of how well the scalp holds onto hair under gentle traction.

Head-to-head data suggests PRP performs comparably to daily topical minoxidil — without the need for ongoing daily application. And when PRP is combined with minoxidil, the additive benefit is clear: one analysis found hair density at three months was significantly higher in the combination group, with a mean difference of 21.81 hairs per area (95% CI: 10.64–33.00).

It is worth acknowledging what the research also shows honestly: individual results vary considerably. Some studies found no significant difference between PRP and placebo, and outcomes are influenced heavily by protocol, preparation quality, and the stage of hair loss at treatment initiation. PRP is not a cure for androgenetic alopecia, and results require maintenance sessions to sustain.

What to Expect from a Scalp PRP Treatment

A standard course begins with three sessions spaced approximately four weeks apart, followed by maintenance every three to six months. Improvement tends to emerge gradually — most patients notice changes at the three-month mark, with the clearest results apparent at around twelve months.

Each session involves a blood draw of approximately 20 to 60 mL, processing in a centrifuge to concentrate the platelets, and injection across the scalp at multiple sites targeting areas of thinning. Some patients combine PRP with microneedling — a technique that creates micro-channels in the scalp to enhance delivery and stimulate an independent collagen response, with evidence suggesting enhanced results compared to injection alone.

Mild soreness, temporary redness, and occasional minor scalp shedding in the first few weeks are all expected and part of the normal response. These resolve without intervention.

PRP for Skin Rejuvenation

How Aging Changes the Skin — and What PRP Can Do About It

Skin aging is a process of loss — loss of collagen density, loss of elasticity, loss of the subcutaneous volume that keeps the face looking full and defined. By the time most people notice fine lines around the eyes or at the corners of the mouth, the dermal scaffold has already been thinning for years.

PRP's application to skin rejuvenation follows the same growth factor logic as its use in musculoskeletal and hair care. When activated platelets are introduced into the dermis, PDGF and TGF-β stimulate resident fibroblasts to produce new collagen and elastin. Histological studies confirm this isn't just a surface-level smoothing effect: one study documented an 89% improvement in collagen optical density in treated areas compared to pre-treatment baseline, with PRP-treated skin showing nearly twice the collagen density of saline-treated controls.

What the Research Shows

A 2024 systematic review of 11 clinical studies covering 382 patients found high satisfaction rates across all 11 studies, with average patient satisfaction exceeding 90% at six-month follow-ups. Documented improvements spanned skin texture, pore size, firmness, elasticity, reduction in pigmented spots, and increased dermal hyaluronic acid levels.

Periorbital fine lines — the crow's feet that tend to appear first and resist topical treatments most stubbornly — showed moderate to good improvement in the range of 39–43% in one analysis, with wrinkle values dropping from a baseline of 30.17 to 20.72 at six weeks post-treatment. Dark circles under the eyes improved by 48–74% in one comparative study. Nasolabial folds showed more modest improvement of 4–13%.

One notable enhancement: combining PRP with hyaluronic acid appears to produce synergistic results, particularly for patients in their 50s seeking improvements in skin firmness and elasticity. The hyaluronic acid provides immediate structural support while PRP initiates the slower, deeper process of collagen remodeling.

The honest note here mirrors hair restoration: while patient satisfaction is consistently high, many primary studies remain relatively small, and formal meta-analysis is limited by variability in protocols and outcome measures. What works for one person may not produce the same result for another. Individual skin health, lifestyle factors, and sun history all influence outcomes.

The Treatment Experience

Most skin rejuvenation protocols follow a series of three sessions, spaced two to three weeks apart, with results continuing to develop over the following months. Some patients combine PRP with microneedling for a more intensive stimulus. Others use PRP alongside laser therapy as part of a comprehensive approach to skin renewal.

The procedure involves preparing PRP from a standard blood draw, then injecting it into target areas of the face using fine needles or a cannula. Mild swelling, flushing, and tenderness typically resolve within 24–72 hours. Many patients return to their regular routine the same day.

PRP for Wound Healing

When Wounds Stall: The Clinical Problem

Chronic wounds — particularly diabetic foot ulcers and venous leg ulcers — represent one of medicine's most persistent challenges. Standard wound care protocols help many patients, but a meaningful subset develops wounds that plateau: not healing, not improving, consuming enormous clinical resources and eroding quality of life.

PRP changes the biochemical environment of a stalled wound. The growth factors it delivers — particularly VEGF, PDGF, and EGF — restart the angiogenic and proliferative phases that have stalled, creating new blood vessel networks, stimulating keratinocyte activity, and accelerating the transition from chronic inflammation to active repair.

Evidence in Chronic and Diabetic Wounds

The evidence base here is among the strongest across all PRP applications. A meta-analysis of 29 randomized controlled trials covering 2,198 wounds found that odds for complete wound closure were more than five times higher in PRP-treated groups compared to controls (OR = 5.32; 95% CI: 3.37–8.40).

For diabetic foot ulcers specifically, PRP significantly increased complete closure rates (relative risk 1.20; 95% CI: 1.09–1.32), shortened time to closure, and reduced wound area and depth. Importantly, PRP did not increase infection risk in diabetic patients — a meaningful safety consideration for this population. All studies examining venous ulcers found increased healing with PRP versus standard care.

RegenLife's diagnostic services help identify the metabolic and circulatory factors that influence wound healing capacity, allowing clinicians to combine PRP with broader strategies for vascular health, blood sugar management, and nutrition.

PRP for Musculoskeletal Conditions

PRP's application to joint pain, tendon injuries, osteoarthritis, and sports injuries is covered in depth in our guide to PRP injections. Briefly: for knee osteoarthritis, network meta-analysis consistently ranks PRP above hyaluronic acid and corticosteroids in both pain reduction and functional improvement, with effects lasting six to twelve months. For tendon conditions like tennis elbow, Achilles tendinitis, and rotator cuff injury, PRP delivers concentrated repair signals to tissue that otherwise heals slowly due to limited blood supply.

The short summary: PRP ranks above both hyaluronic acid and cortisone injections in head-to-head comparisons, with one network meta-analysis placing the efficacy hierarchy as PRP > PRP+HA > HA > placebo > corticosteroids.

Who Is — and Isn't — a Good Candidate for PRP

Characteristics That Support Strong Outcomes

PRP works best when the biology it is stimulating still has meaningful capacity to respond. In practice, that means:

• For hair loss: early-to-moderate androgenetic alopecia where follicles are miniaturized but not yet atrophied; patients who have not fully responded to minoxidil or who prefer to avoid daily pharmaceutical use
• For skin rejuvenation: patients with early-to-moderate signs of photoaging, fine lines, and skin laxity who want a natural, non-synthetic approach
• For joints and tendons: mild to moderate osteoarthritis (Kellgren-Lawrence grades I–III), chronic tendinopathy, and ligament injuries that have not responded to conservative care
• For wounds: chronic diabetic foot ulcers and venous ulcers that have plateaued on standard wound care

Patients with generally healthy platelet function tend to produce more therapeutically potent PRP. Metabolic health, adequate protein intake, and well-managed blood sugar all support stronger healing responses — both in terms of how the body produces PRP and how its tissues respond to the growth factors delivered.

Contraindications and Careful Consideration

Because PRP uses the patient's own biological material, serious adverse events are rare. But certain medical conditions require careful evaluation before proceeding:

• Active infection at the injection site or systemic infection
• Metastatic cancer — growth factors in PRP may stimulate tumor activity; this is a firm contraindication
• Thrombocytopenia or significant anemia, which reduces platelet yield below therapeutic thresholds
• Active autoimmune flares
• Patients on anticoagulant therapy, which affects platelet function
• Patients with sarcoidosis (rare cases of granuloma formation have been documented)

The 2025 GRIIP consensus — an international research group on platelet injections — provides current formal guidance on PRP contraindications across oncological, infectious, and hematological comorbidities. At RegenLife, every PRP candidate undergoes a thorough evaluation to ensure the treatment is appropriate and well-timed.

Smoking significantly reduces the healing response by impairing blood flow and tissue oxygenation. Patients who smoke may produce PRP that is less biologically active and whose tissues respond less robustly to growth factor stimulation.

Comparing PRP to Other Treatment Options

Understanding where PRP fits relative to other approaches helps set realistic expectations. What follows is a practical comparison for the conditions PRP is most commonly used to treat.

The unique position of PRP lies in this space between symptom management and structural repair. Corticosteroids and hyaluronic acid address how something feels; PRP attempts to address why it continues to hurt — or why tissue has stopped regenerating.

Integrating PRP into a Whole-Person Healing Approach

The Environment Inside the Body Shapes the Response

PRP does not operate in isolation. The growth factors it delivers activate pathways that the body's internal state either amplifies or dampens. Nervous system regulation, sleep quality, nutritional status, and chronic stress all shape how efficiently tissues respond to regenerative stimulation.

Patients in sustained states of chronic stress often show slower healing responses — not because PRP is ineffective, but because systemic cortisol elevation and sympathetic nervous system dominance suppress the very cellular repair pathways that PRP is trying to activate. Practices that support parasympathetic activation — restorative sleep, breathwork, gentle movement — create the internal conditions where PRP's biological signals land most effectively.

Adequate protein intake provides the raw material for collagen synthesis. Omega-3 fatty acids modulate the inflammatory phase in ways that support tissue remodeling. Vitamin D and zinc are both involved in immune regulation and tissue repair. At RegenLife, lifestyle medicine and physical therapy often work alongside regenerative injections — because the injection initiates healing, and the broader environment determines how far that healing goes.

When PRP Is Part of a Layered Treatment Plan

RegenLife's multidisciplinary approach means PRP is rarely considered in isolation. For patients with joint pain that also involves chronic pain pathways, behavioral health support addresses the nervous system dimension of pain amplification. For patients with hair loss accompanied by hormonal changes, evaluation through hormone therapy may identify treatable contributors — since DHT sensitivity, thyroid function, and cortisol patterns all influence follicular health.

For patients managing metabolic conditions that affect wound healing or joint inflammation, diagnostic services and ongoing metabolic support create a foundation that makes any regenerative intervention more effective.